Expanded Insights in Pharmaceutical Chemistry
The updated second edition delivers expanded insights into solid-state pharmaceutical materials, reflecting major scientific and regulatory advances in drug development.
The release of the highly anticipated second edition of Solid-State Materials in Pharmaceutical Chemistry: Properties, Characterization, and Applications has been announced by Improved Pharma. Co-authored by distinguished experts Stephen R. Byrn, George Zografi, and Xiaoming (Sean) Chen, this comprehensive volume serves as an essential resource for scientists and researchers navigating the complex landscape of drug development.
Exploring Solid-State Properties
The new edition provides an in-depth exploration of the solid-state properties of pharmaceutical materials, a critical factor in ensuring the safety, efficacy, and stability of medicines. Updated to reflect significant advancements in the field, the book covers a wide range of topics including small molecule compounds, peptides, proteins, and the latest regulatory considerations.
Insight from Industry Experts
Stephen R. Byrn, co-author of the book and CSO of Improved Pharma, noted, "This second edition represents a major milestone in our understanding of pharmaceutical solids. The pharmaceutical landscape has shifted dramatically since our last edition, particularly with the rise of complex molecules and accelerated development timelines. Our goal was to create a guide that not only addresses these new challenges but also empowers scientists with the fundamental principles needed to innovate and solve the toughest problems in formulation and manufacturing."
A Comprehensive Resource for Researchers
The book combines theoretical foundations with practical applications, making it an indispensable tool for both academic researchers and industry professionals. It details the characterization of polymorphs, solvates, and amorphous forms, while offering strategies for controlling these properties throughout the drug product lifecycle.
Expert Contributions and Future Impact
Pamela Smith, COO of Improved Pharma, expressed pride in the contributions made by the authors, stating, "We are incredibly proud to see this level of expertise shared with the broader scientific community. Stephen, George, and Sean have distilled decades of experience into a resource that will undoubtedly shape the future of pharmaceutical development. At Improved Pharma, we witness the impact of these solid-state principles every day as we help our clients bring life-saving therapies to market, and this book captures that cutting-edge knowledge perfectly."
Key Details About the Book
Solid-State Materials in Pharmaceutical Chemistry: Properties, Characterization, and Applications, 2nd Edition offers a rigorous examination of the physical properties of pharmaceutical solids. It is available for purchase through major retailers, including Amazon and Wiley.
About Improved Pharma
Improved Pharma is a research, consulting, and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. Founded in 2006 by Stephen and Sarah Byrn, the company is well-regarded in the pharmaceutical landscape.
For more information about Improved Pharma's services, please visit their official website.
Frequently Asked Questions
What is the focus of the new edition of the book?
The new edition focuses on the solid-state properties of pharmaceutical materials, reflecting advancements in drug development.
Who are the authors of the book?
The book is co-authored by Stephen R. Byrn, George Zografi, and Xiaoming (Sean) Chen, experts in the field.
Why is this book significant for researchers?
This book serves as an essential resource that combines theoretical knowledge with practical applications, beneficial for both researchers and professionals.
How has the pharmaceutical landscape changed since the last edition?
The landscape has shifted with the rise of complex molecules and accelerated development timelines, necessitating updated strategies for drug formulation.
Where can readers purchase the book?
The book is available at major retailers including Amazon and Wiley.
